ENHO and Obesity: Indeed, low circulating levels of adropin, which has potent powerful organ-protective properties, are associated with the presence of cardiovascular and metabolic risk factors, such as atherosclerosis, hypertension, obesity, insulin resistance, chronic kidney disease and dyslipidaemia.